One Scientist’s Quest to Bring DNA Sequencing to Every Sick Kid

Although doctors didn’t know how to cure Massimo’s leukodystrophy, they knew enough about his disease that they could tell the Damianis what had helped other patients. One of those interventions was giving him high doses of a steroid. For 18 months, Massimo, whose irritability made it difficult to go out, was happier and more engaged with people, until the medicine lost its effectiveness.

But the parents they met whose children were similarly affected often had the best advice. “You start to share your stories, and you learn what works and what doesn’t work,” Damiani says. One family suggested giving Massimo the drug baclofen through an implant that injected it into his spine to relieve the stiffness in his legs.

Other parents explained how they soothed their young daughter who, like, Massimo became inconsolable for an hour at a time after being exposed to bright lights or sudden noises. The trick was to put the child in a quiet, dark room in his underwear, and he calmed down within five minutes. “This girl gave Massimo a voice, and he only had a voice because he had a diagnosis,” Damiani says.

web site
website link
what do you think
what google did to me
what is it worth
why not check here
why not find out more
why not look here
why not try here
why not try these out
why not try this out
you can check here
you can find out more
you can look here
you can try here
you can try these out
you can try this out
you could check here
you could look here
you could try here
you could try these out
you could try this out
your domain name
your input here
have a peek at this web-site
have a peek here
Check This Out
this contact form
navigate here
his comment is here
check over here
this content
have a peek at these guys
check my blog
More about the author
click site
navigate to this website
my review here
get redirected here
useful reference
this page
Get More Info
see here
this website
great post to read
my company
imp source
click to read more
find more info
see it here
a fantastic read
find this
read this article

The end of Massimo’s diagnostic odyssey also meant doctors could stop invasive testing. “He would have needles stuck in him, anesthesia, and claustrophobic MRIs,” Damiani says. “When he had to get a muscle biopsy, they used a device that looked like a small apple corer to take out a piece of his arm muscle. It felt terrible as a parent that he only associated doctors with pain.”

A diagnosis improved Massimo’s life. It was also the first step toward finding a cure. It was hope.

When the genetic link to Massimo’s illness was identified, the team celebrated with an official patch and “Mission Accomplished” certificate.


Sinead Kennedy

Taft was now a father to a year-old baby girl, and he was surprised at the emotion that would surface within him whenever she cried out in pain. Fatherhood had connected him to the struggle of parents with sick children in a whole new way. In the meantime, he and Damiani had developed a deep friendship, and he was constantly moved by the father’s devotion to his son.

Taft originally had taken on the challenge of helping the Damianis to do something good at the time, but he couldn’t ignore the fact that the experience had given him a new purpose—in a field where he could make an immediate impact.

Every year, Taft had a tradition. He’d sit in the Brisbane library overlooking the river with a big piece of butcher paper. He’d write down his goals—or ask the big questions he wanted to answer—and then make more lists and draw lines and arrows to see if he was on the right path.

But this Saturday morning he quickly asked himself the most direct question of all about his new calling: “How would I feel if I dropped all of that?”

Within a couple weeks, he contacted a colleague at Illumina and asked if there was a place for him there. “It’s funny you should call now,” he remembers her saying. “[Chief scientist and VP] David Bentley and Jay Flatley were just asking about you.”

In April 2014, Taft was hired as the director of scientific research at Illumina, three months after the $1,000 genome was announced to the public. The family—now with a son on the way—had moved back to his hometown of San Diego for the job. On his first day, Taft handed Bentley, his new boss, a four-page document outlining his vision for the future of personalized medicine. “I want to bring a genome to every kid who needs one,” he told him. “We start small and then we scale globally.”

Taft had proposed opening a clinic at Illumina, but that wasn’t practical. Instead, the company would focus on partnering with hospitals and helping them set up labs. In the process they’d be getting more research results, showing people in the clinics the value of genetic sequencing, training a workforce, continuing to develop sequencing technology, and improving the interpretation of vast amounts of data.

Leave a Reply

Your email address will not be published.